Ares Financial Consulting’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15K Sell
12
-35
-74% -$3.36K ﹤0.01% 985
2026
Q1
$4.9K Buy
47
+35
+292% +$3.97K ﹤0.01% 685
2025
Q4
$1.21K Buy
+12
New +$1.3K ﹤0.01% 740

Other funds holding CLX

Ares Financial Consulting's CLX Position: Q2 2026 in Review

Ares Financial Consulting reduced its Clorox (CLX) stake by 74% in Q2 2026, selling an estimated $3.36K and leaving 12 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Ares Financial Consulting first reported a position in CLX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.9K in Q1 2026. 533 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Ares Financial Consulting held 12 shares of Clorox worth $1.15K as of Q2 2026.
  • Ares Financial Consulting sold 35 Clorox shares in Q2 2026, an estimated $3.36K.
  • Clorox made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #985 holding.
  • Ares Financial Consulting first reported a position in Clorox in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Clorox position peaked at $4.9K in Q1 2026.
  • 533 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.